Skip to content
MamaGLP — home

Head to head for first-timers

CoreAge Rx vs LevelsRx

CoreAge Rx and LevelsRx both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.

CoreAge Rx

Higher score

Rank #31 for first-timers · Grade C

Mama-Match

Best for: Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.

Visit CoreAge Rx
vs

LevelsRx

Rank #226 for first-timers · Grade C

Mama-Match

Best for: If you take the three prices at face value and ignore every statistic on the page.

Visit LevelsRx

The verdict for a first step

Higher Mama-Match Score: CoreAge Rx

CoreAge Rx edges out LevelsRx on the Mama-Match Score, 73 to 49 (C vs C). Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.

LevelsRx is still a genuine option — the prices are ordinary: $150 for compounded semaglutide, $240 for tirzepatide, $150 for an oral liposomal version. What surrounds them is not. That "94.6% success rate" and "14+ lbs avg. weight loss" rest on a note citing "approximately 66,260 Remedy Meds members" — a different company, the white-label platform this site runs on. Another note on the same page says "approximately 50,000 members". And the live review widget says: six reviews, one member. Weigh the six first-timer factors below against your own priorities.

Side by side on all six factors

Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.

CoreAge Rx LevelsRx
Gentle, easy start8240
CoreAge
LevelsRx
Honest, upfront pricing7280
CoreAge
LevelsRx
Real clinician support8448
CoreAge
LevelsRx
Available nationwide5552
CoreAge
LevelsRx
Ongoing help & check-ins7830
CoreAge
LevelsRx
Simple, fair cancellation5546
CoreAge
LevelsRx

Price, access and features

DetailCoreAge RxLevelsRx
Mama-Match Score73/100 · C49/100 · C
Overall rank#31#226
Semaglutide$99/moFrom $150/mo
Tirzepatide$149/moFrom $240/mo
CoverageTherapy-specific state restrictions; confirm eligibilityNot published; described only as "Nationwide"
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes

Mama-Match

CoreAge Rx

Rank #31 · Grade C

What we like

  • Published prices for both molecules, with the same advertised amount at each dose
  • The offer includes medication, consultation and shipping, without an advertised membership fee
  • The legal footer identifies the platform and the entities responsible for clinical care

The caveats

  • The main site and a separate offer page show different prices
  • The FAQ and policy differ on automatic rebilling and denial refunds
  • State restrictions; orders become final when sent to pharmacy, with a 30-day refund cutoff

Mama-Match

LevelsRx

Rank #226 · Grade C

What we like

  • Three products priced separately, including an oral liposomal semaglutide at the same price as the injection
  • Claims LegitScript certification
  • A stated money-back guarantee: "Hit your target with us, or we refund 100% of your money"

The caveats

  • Its headline statistics are backed by "approximately 66,260 Remedy Meds members": the white-label platform it runs on, not its own patients
  • Another note on the same page gives the sample as "approximately 50,000 members", so the two do not match
  • The live review widget reads "Great 4.2 | 6 Reviews 1 Member" just below "1M+ Users on GLP-1"

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.

More head-to-heads

Keep comparing CoreAge Rx and LevelsRx with the other providers we review for women.

Or browse the full comparison hub.